eltrombopag

Generic: eltrombopag

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name eltrombopag
Generic Name eltrombopag
Labeler camber pharmaceuticals, inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

eltrombopag olamine 12.5 mg/1

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-841
Product ID 31722-841_3de3bb2e-97bf-4a59-e063-6294a90a7744
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206788
Listing Expiration 2026-12-31
Marketing Start 2025-05-13

Pharmacologic Class

Classes
breast cancer resistance protein inhibitors [moa] increased megakaryocyte maturation [pe] increased platelet production [pe] organic anion transporting polypeptide 1b1 inhibitors [moa] thrombopoietin receptor agonist [epc] thrombopoietin receptor agonists [moa] ugt1a1 inhibitors [moa] ugt1a3 inhibitors [moa] ugt1a4 inhibitors [moa] ugt1a6 inhibitors [moa] ugt1a9 inhibitors [moa] ugt2b15 inhibitors [moa] ugt2b7 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722841
Hyphenated Format 31722-841

Supplemental Identifiers

RxCUI
825421 825427 884617 1245001
UPC
0331722841306 0331722844307 0331722842303 0331722843300
UNII
4U07F515LG

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name eltrombopag (source: ndc)
Generic Name eltrombopag (source: ndc)
Application Number ANDA206788 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 12.5 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE (31722-841-30)
source: ndc

Packages (1)

31722-841-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-841-30)

Ingredients (1)

eltrombopag olamine (12.5 mg/1)

Linked Drug Pages (1)

ELTROMBOPAG ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3de3bb2e-97bf-4a59-e063-6294a90a7744", "openfda": {"upc": ["0331722841306", "0331722844307", "0331722842303", "0331722843300"], "unii": ["4U07F515LG"], "rxcui": ["825421", "825427", "884617", "1245001"], "spl_set_id": ["e913cd11-f5fb-4ebe-81c7-0c5626b52cfd"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (31722-841-30)", "package_ndc": "31722-841-30", "marketing_start_date": "20250513"}], "brand_name": "ELTROMBOPAG", "product_id": "31722-841_3de3bb2e-97bf-4a59-e063-6294a90a7744", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Increased Megakaryocyte Maturation [PE]", "Increased Platelet Production [PE]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Thrombopoietin Receptor Agonist [EPC]", "Thrombopoietin Receptor Agonists [MoA]", "UGT1A1 Inhibitors [MoA]", "UGT1A3 Inhibitors [MoA]", "UGT1A4 Inhibitors [MoA]", "UGT1A6 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B15 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]"], "product_ndc": "31722-841", "generic_name": "ELTROMBOPAG", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ELTROMBOPAG", "active_ingredients": [{"name": "ELTROMBOPAG OLAMINE", "strength": "12.5 mg/1"}], "application_number": "ANDA206788", "marketing_category": "ANDA", "marketing_start_date": "20250513", "listing_expiration_date": "20261231"}